Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents

ISSN： 0033-3158

Source： Psychopharmacology, Vol.191, Iss.1, 2007-03, pp. : 127-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents

By Hawkridge S.M. Stein D.J.

Drug Safety, Vol. 19, Iss. 4, 1998-10 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for children and adolescents with epilepsy

By Verrotti Alberto Loiacono Giulia Coppola Giangennaro Spalice Alberto Mohn Angelika Chiarelli Francesco

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 175-194

Informa Healthcare

Access to resources Recommend Favorite

Fluvoxamine: A Review of its Therapeutic Potential in the Management of Anxiety Disorders in Children and Adolescents

By Cheer S.M. Figgitt D.P.

Pediatric Drugs, Vol. 3, Iss. 10, 2001-01 ,pp. : 763-781

Adis International

Access to resources Recommend Favorite

Management of Schizophrenia in Children and Adolescents: Focus on Pharmacotherapy

By Masi Gabriele Liboni Francesca

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 179-208

Adis International

Access to resources Recommend Favorite

Efficacy of antidepressant medications in children and adolescents with non-obsessive–compulsive disorder anxiety disorders: a systematic assessment

By Gentile Salvatore

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 735-744

Informa Healthcare

Access to resources Recommend Favorite